JoVE Logo

Sign In

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

5.3K Views

07:17 min

January 29th, 2021

DOI :

10.3791/62033-v

January 29th, 2021


Explore More Videos

Murine Ommaya Model

Chapters in this video

0:04

Introduction

1:07

Injection of CTCs into CSF to Generate a Mouse LMD Model

3:37

Murine Ommaya Assembly and Implantation

5:20

Results: Direct-Targeted Immunotherapy Using the Murine Ommaya Increases the Overall Survival of Breast Cancer-Associated Leptomeningeal Disease Mice

6:37

Conclusion

Related Videos

article

08:11

A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice

23.0K Views

article

08:02

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

16.3K Views

article

05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

6.7K Views

article

09:52

An Orthotopic Glioblastoma Mouse Model Maintaining Brain Parenchymal Physical Constraints and Suitable for Intravital Two-photon Microscopy

19.6K Views

article

07:37

Translational Orthotopic Models of Glioblastoma Multiforme

2.5K Views

article

06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

753 Views

article

10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

13.0K Views

article

09:10

An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma

325 Views

article

11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

7.8K Views

article

01:38

Surgical Cisterna Magna Injection: A Method for Administering Tumor Cells Directly into Central Nervous System of Murine Model

5.8K Views

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved